David J. Clanton

1.7k total citations
37 papers, 1.4k citations indexed

About

David J. Clanton is a scholar working on Virology, Infectious Diseases and Oncology. According to data from OpenAlex, David J. Clanton has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 17 papers in Infectious Diseases and 11 papers in Oncology. Recurrent topics in David J. Clanton's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (16 papers) and Cancer-related Molecular Pathways (7 papers). David J. Clanton is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (16 papers) and Cancer-related Molecular Pathways (7 papers). David J. Clanton collaborates with scholars based in United States, Japan and Ukraine. David J. Clanton's co-authors include Thomas Y. Shih, Robert W. Buckheit, William G. Rice, Jim A. Turpin, John P. Bader, Lisa M. Graham, Satoshi Hattori, Catherine A. Schaeffer, O. S. Weislow and Ming Bu and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David J. Clanton

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Clanton United States 22 684 560 455 235 193 37 1.4k
Lawrence R. Boone United States 23 643 0.9× 727 1.3× 725 1.6× 312 1.3× 289 1.5× 37 1.5k
Kenji Okonogi Japan 23 596 0.9× 465 0.8× 685 1.5× 237 1.0× 397 2.1× 54 1.9k
Ian Bathurst United States 25 820 1.2× 291 0.5× 302 0.7× 231 1.0× 139 0.7× 65 2.1k
Stephen Oroszlan United States 19 828 1.2× 374 0.7× 285 0.6× 163 0.7× 109 0.6× 28 1.6k
Mukund J. Modak United States 27 1.3k 1.9× 545 1.0× 642 1.4× 153 0.7× 119 0.6× 85 1.9k
Joseph M. Colacino United States 24 730 1.1× 347 0.6× 618 1.4× 794 3.4× 191 1.0× 67 2.0k
A G Tomasselli United States 14 639 0.9× 739 1.3× 778 1.7× 110 0.5× 171 0.9× 19 1.3k
André Kirn France 26 523 0.8× 452 0.8× 755 1.7× 611 2.6× 291 1.5× 57 2.0k
Marina K. Kukhanova Russia 21 933 1.4× 187 0.3× 546 1.2× 362 1.5× 285 1.5× 111 1.6k
Wayne K. Herber United States 13 926 1.4× 555 1.0× 612 1.3× 100 0.4× 200 1.0× 21 1.6k

Countries citing papers authored by David J. Clanton

Since Specialization
Citations

This map shows the geographic impact of David J. Clanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Clanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Clanton more than expected).

Fields of papers citing papers by David J. Clanton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Clanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Clanton. The network helps show where David J. Clanton may publish in the future.

Co-authorship network of co-authors of David J. Clanton

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Clanton. A scholar is included among the top collaborators of David J. Clanton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Clanton. David J. Clanton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Richard N., Jeffrey S. Kennedy, David J. Clanton, et al.. (2005). Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. The Lancet. 365(9457). 398–409. 46 indexed citations
2.
Manischewitz, Jody, Lisa R. King, Joseph Shiloach, et al.. (2003). Development of a Novel Vaccinia‐Neutralization Assay Based on Reporter‐Gene Expression. The Journal of Infectious Diseases. 188(3). 440–448. 53 indexed citations
3.
Randad, Ramnarayan S., Lucyna Lubkowska, Michael A. Eissenstat, et al.. (1998). Unsymmetric nonpeptidic HIV protease inhibitors containing anthranilamide as a P2′ ligand. Bioorganic & Medicinal Chemistry Letters. 8(24). 3537–3542. 1 indexed citations
4.
Rice, William G., Jim A. Turpin, Mingjun Huang, et al.. (1997). Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nature Medicine. 3(3). 341–345. 83 indexed citations
5.
Tobin, Gregory J., Willis H. Ennis, David J. Clanton, & Matthew A. Gonda. (1996). Inhibition of bovine immunodeficiency virus by anti-HIV-1 compounds in a cell culture-based assay. Antiviral Research. 33(1). 21–31. 12 indexed citations
6.
Turpin, Jim A., Catherine A. Schaeffer, Ming Bu, et al.. (1996). Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor. Antiviral Research. 29(2-3). 269–277. 32 indexed citations
7.
Kiser, Rebecca, et al.. (1996). Assessment of a cytoprotection assay for the discovery and evaluation of anti-human immunodeficiency virus compounds utilizing a genetically-impaired virus. Journal of Virological Methods. 58(1-2). 99–109. 38 indexed citations
8.
Lackman-Smith, Carol, John P. Bader, William G. Rice, et al.. (1996). Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene. Antiviral Research. 33(1). 41–53. 14 indexed citations
9.
Clanton, David J., R W Buckheit, Rebecca Kiser, et al.. (1995). Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV. Antiviral Research. 27(4). 335–354. 41 indexed citations
10.
Randad, Ramnarayan S., Lucyna Lubkowska, A. Bujacz, et al.. (1995). Structure-based design of achiral anthranilamides as P2/P2′ surrogates for symmetry-based HIV protease inhibitors: design, synthesis, X-ray structure, enzyme inhibition and antiviral activity. Bioorganic & Medicinal Chemistry Letters. 5(21). 2557–2562. 4 indexed citations
11.
Rice, William G., Jeffrey G. Supko, Louis Malspeis, et al.. (1995). Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS. Science. 270(5239). 1194–1197. 195 indexed citations
12.
Kiser, Rebecca, et al.. (1995). Development of a non-hazardous biological assay system for the screening of anti-HIV compounds. Antiviral Research. 26(3). A252–A252. 1 indexed citations
13.
Cushman, Mark, W. Marek Gołębiewski, James B. McMahon, et al.. (1994). Design, Synthesis, and Biological Evaluation of Cosalane, a Novel Anti-HIV Agent Which Inhibits Multiple Features of Virus Reproduction. Journal of Medicinal Chemistry. 37(19). 3040–3050. 48 indexed citations
14.
Clanton, David J., O. S. Weislow, Robert W. Buckheit, et al.. (1992). Sulfonic acid dyes: inhibition of the human immunodeficiency virus and mechanism of action.. PubMed. 5(8). 771–81. 25 indexed citations
15.
Clanton, David J., James B. McMahon, O. S. Weislow, et al.. (1992). Sulfonic Acid Dyes. 5(8). 771???781–771???781. 15 indexed citations
16.
Lu, Youyong, Donald G. Blair, Shraga Segal, Thomas Y. Shih, & David J. Clanton. (1991). Tumorigenicity, metastasis and suppression of MHC class-I expression in murine fibroblasts transformed by mutantv-ras deficient in GTP binding. International Journal of Cancer. 47(S6). 45–53. 11 indexed citations
17.
Halverson, Douglas, W.S. Modi, Michael Dean, et al.. (1990). An oncogenic chromosome 8-9 gene fusion isolated following transfection of human ovarian carcinoma cell line DNA.. PubMed. 5(7). 1085–9. 4 indexed citations
18.
Hattori, Seisuke, David J. Clanton, Takaya Satoh, et al.. (1987). Neutralizing Monoclonal Antibody Against Ras Oncogene Product p21 Which Impairs Guanine Nucleotide Exchange. Molecular and Cellular Biology. 7(5). 1999–2002. 17 indexed citations
19.
Hoshino, Masato, David J. Clanton, Thomas Y. Shih, Masao Kawakita, & Seisuke Hattori. (1987). Interaction of ras Oncogene Product p21 with Guanine Nucleotides1. The Journal of Biochemistry. 102(3). 503–511. 30 indexed citations
20.
Clanton, David J., Youyong Lu, Donald G. Blair, & Thomas Y. Shih. (1987). Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis.. Molecular and Cellular Biology. 7(9). 3092–3097. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence R. Boone Breakdown of academic impact, for papers by Kenji Okonogi Breakdown of academic impact, for papers by Ian Bathurst Breakdown of academic impact, for papers by Stephen Oroszlan Breakdown of academic impact, for papers by Mukund J. Modak Breakdown of academic impact, for papers by Joseph M. Colacino Breakdown of academic impact, for papers by A G Tomasselli Breakdown of academic impact, for papers by André Kirn Breakdown of academic impact, for papers by Marina K. Kukhanova Breakdown of academic impact, for papers by Wayne K. Herber
Rankless by CCL
2026